8-KEarnings & ResultsExhibits & Filings

AbbVie Inc. 8-K Report, Financial Results (Apr 21, 2022)

Filed April 21, 2022For Securities:ABBV

Summary

AbbVie Inc. filed a Form 8-K on April 21, 2022, primarily to provide investors with a revised reconciliation of its reported GAAP and non-GAAP financial results for the periods ended December 31, 2021 (both quarter-to-date and year-to-date). This filing indicates a retroactive adjustment to how the company presents its performance metrics beyond generally accepted accounting principles. While this 8-K doesn't contain new operational or strategic announcements, the revised non-GAAP reconciliation is significant for investors who rely on these metrics for a clearer understanding of underlying business performance, excluding certain items like stock-based compensation, amortization, and other discrete items. Investors should review Exhibit 99.1 to understand the specific adjustments made and their impact on the reported non-GAAP figures, as these adjustments can influence comparisons to prior periods and to industry peers.

Key Highlights

  • 1Filing of an 8-K on April 21, 2022, by AbbVie Inc. (ABBV).
  • 2The primary purpose is to provide revised financial information.
  • 3Exhibit 99.1 includes a revised reconciliation of GAAP to non-GAAP results for year-end 2021.
  • 4Reconciliation covers both quarter-to-date and year-to-date periods for the year ended December 31, 2021.
  • 5This filing does not disclose new operational results or forward-looking guidance.
  • 6The filing includes standard XBRL formatted cover page as Exhibit 104.

Frequently Asked Questions

The main purpose of this 8-K filing is to present a revised reconciliation of AbbVie's reported GAAP (Generally Accepted Accounting Principles) financial results to its non-GAAP financial results for the periods ending December 31, 2021, including both quarter-to-date and year-to-date figures.

No, this 8-K filing does not provide any new operational results, earnings announcements, or forward-looking guidance. Its sole purpose is to update the reconciliation of historical non-GAAP financial measures.

A revised non-GAAP reconciliation is important for investors because non-GAAP measures are often used by management to provide a view of the company's performance excluding certain items that may not be indicative of ongoing operational trends. Understanding the adjustments made to derive these non-GAAP figures allows investors to better assess the company's underlying business performance, compare results across periods, and evaluate the company's financial health.

The detailed revised reconciliation of reported GAAP and non-GAAP results for the year ended December 31, 2021, can be found in Exhibit 99.1, which is included as part of this Current Report on Form 8-K.